Inventor · disambiguated record
Balkrishen Bhat
Also filed as: BHAT BALKRISHEN
79 granted patents·73 pending applications·5,968 citations·filing 1997–2025
99Inventor score
Files withISIS PHARMACEUTICALS INC32REGULUS THERAPEUTICS INC31BHAT BALKRISHEN25TRANSLATE BIO MA INC8IONIS PHARMACEUTICALS INC7
Top patents by PatentIndex Score
152 records- 0199US9005906B2Tetrahydropyran nucleic acid analogsISIS PHARMACEUTICALS INC·Filed 2014·Granted Apr 14, 2015·163 cites·24 claims
- 0299US8440803B2Tetrahydropyran nucleic acid analogsSWAYZE ERIC E·Filed 2011·Granted May 14, 2013·158 cites·16 claims
- 0399US8268980B25′-modified bicyclic nucleic acid analogsSETH PUNIT P·Filed 2011·Granted Sep 18, 2012·182 cites·18 claims
- 0499US8030467B25′-modified bicyclic nucleic acid analogsISIS PHARMACEUTICALS INC·Filed 2010·Granted Oct 4, 2011·327 cites·26 claims
- 0599US7750131B25′-modified bicyclic nucleic acid analogsISIS PHARMACEUTICALS INC·Filed 2009·Granted Jul 6, 2010·202 cites·40 claims
- 0699US7696345B2Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulationISIS PHARMACEUTICALS INC·Filed 2003·Granted Apr 13, 2010·426 cites·24 claims
- 0799US7547684B25′-modified bicyclic nucleic acid analogsISIS PHARMACEUTICALS INC·Filed 2007·Granted Jun 16, 2009·413 cites·50 claims
- 0898US8796437B2Tetrahydropyran nucleic acid analogsISIS PHARMACEUTICALS INC·Filed 2013·Granted Aug 5, 2014·85 cites·23 claims
- 0998US8124745B2Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulationALLERSON CHARLES·Filed 2010·Granted Feb 28, 2012·203 cites·20 claims
- 1098US8088904B2Tetrahydropyran nucleic acid analogsSWAYZE ERIC E·Filed 2008·Granted Jan 3, 2012·164 cites·30 claims
- 1198US7939677B2Oligomeric compounds comprising 4′-thionucleosides for use in gene modulationISIS PHARMACEUTICALS INC·Filed 2010·Granted May 10, 2011·152 cites·20 claims
- 1298US7875733B2Oligomeric compounds comprising 4′-thionucleosides for use in gene modulationISIS PHARMACEUTICALS INC·Filed 2004·Granted Jan 25, 2011·159 cites·6 claims
- 1398US7569686B1Compounds and methods for synthesis of bicyclic nucleic acid analogsISIS PHARMACEUTICALS INC·Filed 2007·Granted Aug 4, 2009·501 cites·26 claims
- 1498US7125855B2Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymeraseMERCK & CO INC·Filed 2003·Granted Oct 24, 2006·301 cites·4 claims
- 1598US7105499B2Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymeraseISIS PHARMACEUTICALS INC·Filed 2002·Granted Sep 12, 2006·233 cites·2 claims
- 1698US6861514B2Nucleosidic and non-nucleosidic folate conjugatesISIS PHARMACEUTICALS INC·Filed 2001·Granted Mar 1, 2005·122 cites·33 claims
- 1798US6777395B2Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase of hepatitis C virusMERCK & CO INC·Filed 2002·Granted Aug 17, 2004·356 cites·13 claims
- 1898US6528631B1Oligonucleotide-folate conjugatesISIS PHARMACEUTICALS INC·Filed 1998·Granted Mar 4, 2003·461 cites·42 claims
- 1998US6335434B1Nucleosidic and non-nucleosidic folate conjugatesISIS PHARMACEUTICALS INC·Filed 1999·Granted Jan 1, 2002·558 cites·4 claims
- 2097US7541344B2Modulation of survivin expressionLILLY CO ELI·Filed 2004·Granted Jun 2, 2009·119 cites·24 claims
- 2197US7534767B2C-purine nucleoside analogs as inhibitors of RNA-dependent RNA viral polymeraseMERCK & CO INC·Filed 2005·Granted May 19, 2009·69 cites·23 claims
- 2296US10266825B2Compositions comprising alternating 2′-modified nucleosides for use in gene modulationIONIS PHARMACEUTICALS INC·Filed 2017·Granted Apr 23, 2019·10 cites·21 claims
- 2396US9359609B2Methods for treatment of alport syndromeREGULUS THERAPEUTICS INC·Filed 2015·Granted Jun 7, 2016·26 cites·20 claims
- 2495US9309513B2MicroRNA compounds and methods for modulating miR-122REGULUS THERAPEUTICS INC·Filed 2014·Granted Apr 12, 2016·13 cites·15 claims
- 2595US8129515B2Oligomeric compounds and compositions for the use in modulation of microRNAsESAU CHRISTINE·Filed 2007·Granted Mar 6, 2012·60 cites·27 claims
- 2694US9738895B2Oligomeric compounds and methodsIONIS PHARMACEUTICALS INC·Filed 2015·Granted Aug 22, 2017·10 cites·21 claims
- 2794US9506030B2Compounds and methods for enhanced cellular uptakeREGULUS THERAPEUTICS INC·Filed 2014·Granted Nov 29, 2016·18 cites·25 claims
- 2894US8987435B2Oligomeric compounds and methodsSWAYZE ERIC E·Filed 2009·Granted Mar 24, 2015·20 cites·23 claims
- 2994US8912161B2MicroRNA compounds and methods for modulating miR-21 activityREGULUS THERAPEUTICS INC·Filed 2014·Granted Dec 16, 2014·15 cites·10 claims
- 3093US9574194B2MicroRNA compounds and methods for modulating miR-122REGULUS THERAPEUTICS INC·Filed 2016·Granted Feb 21, 2017·5 cites·34 claims
- 3193US9157083B2MicroRNA compounds and methods for modulating miR-122REGULUS THERAPEUTICS INC·Filed 2014·Granted Oct 13, 2015·9 cites·20 claims
- 3293US9127272B2Oligomeric compounds and compositions for the use in modulation of target nucleic acidsESAU CHRISTINE·Filed 2012·Granted Sep 8, 2015·17 cites·9 claims
- 3392US9708610B2Compositions comprising alternating 2′-modified nucleosides for use in gene modulationIONIS PHARMACEUTICALS INC·Filed 2015·Granted Jul 18, 2017·6 cites·19 claims
- 3492US9267137B2MicroRNA compounds and methods for modulating miR-21 activityREGULUS THERAPEUTICS INC·Filed 2015·Granted Feb 23, 2016·8 cites·21 claims
- 3592US9012423B2Methods for treatment of alport syndromeREGULUS THERAPEUTICS INC·Filed 2013·Granted Apr 21, 2015·13 cites·26 claims
- 3692US7323449B2Thionucleoside derivatives as inhibitors of RNA-dependent RNA viral polymeraseMERCK & CO INC·Filed 2003·Granted Jan 29, 2008·58 cites·15 claims
- 3791US9181547B2MicroRNA compounds and methods for modulating MIR-21 activityBHAT BALKRISHEN·Filed 2012·Granted Nov 10, 2015·12 cites·6 claims
- 3891US8481712B2Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymeraseBHAT BALKRISHEN·Filed 2007·Granted Jul 9, 2013·48 cites·11 claims
- 3991US7919612B22′-substituted oligomeric compounds and compositions for use in gene modulationsISIS PHARMACEUTICALS INC·Filed 2003·Granted Apr 5, 2011·14 cites·12 claims
- 4090US9688985B2MicroRNA compounds and methods for modulating miR-21 activityREGULUS THERAPEUTICS INC·Filed 2016·Granted Jun 27, 2017·6 cites·6 claims
- 4190US8969317B2MicroRNA compounds and methods for modulating miR-21 activityREGULUS THERAPEUTICS INC·Filed 2013·Granted Mar 3, 2015·9 cites·15 claims
- 4290US8604183B2Compositions comprising alternating 2′-modified nucleosides for use in gene modulationALLERSON CHARLES·Filed 2003·Granted Dec 10, 2013·20 cites·24 claims
- 4390US7425544B2Modulation of eIF4E expressionLILLY CO ELI·Filed 2004·Granted Sep 16, 2008·26 cites·16 claims
- 4489US9139832B2Oligomeric compounds and compositions for use in modulation of small non-coding RNAsREGULUS THERAPEUTICS INC·Filed 2014·Granted Sep 22, 2015·4 cites·20 claims
- 4588US9790496B2Microrna compounds and methods for modulating MIR-21 activityREGULUS THERAPEUTICS INC·Filed 2015·Granted Oct 17, 2017·4 cites·15 claims
- 4688US9598693B2Oligomeric compounds and compositions for the use in modulation of micrornasIONIS PHARMACEUTICALS INC·Filed 2015·Granted Mar 21, 2017·3 cites·15 claims
- 4788US9193752B25′-substituted bicyclic nucleosides and oligomeric compounds prepared therefromMIGAWA MICHAEL T·Filed 2011·Granted Nov 24, 2015·14 cites·25 claims
- 4888US8846631B2MicroRNA compositions and methodsMARCUSSON ERIC G·Filed 2011·Granted Sep 30, 2014·9 cites·15 claims
- 4988US8779118B2Base modified bicyclic nucleosides and oligomeric compounds prepared therefromALLERSON CHARLES·Filed 2011·Granted Jul 15, 2014·14 cites·42 claims
- 5087US9970011B2Methods for treatment of alport syndromeREGULUS THERAPEUTICS INC·Filed 2017·Granted May 15, 2018·4 cites·11 claims
Showing the top 50 of 152 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →